國家衛生研究院 NHRI:Item 3990099045/8621
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 862690      線上人數 : 754
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/8621


    題名: Efficacy of appropriate antimicrobial therapy on the survival of patients with carbapenem non-susceptible Klebsiella pneumoniae infection: A multicenter study in Taiwan
    作者: Lin, YT;Chuang, C;Su, CF;Chuang, YC;Siu, LK;Fung, CP
    貢獻者: Division of Infectious Diseases
    摘要: Purpose: The impact of antimicrobial treatment on the outcome of carbapenem non-susceptible K. pneumoniae (CnsKP) infections needs to be elucidated. This nationwide, multicenter study was conducted to evaluate the impact of appropriate antimicrobial therapy on 14-day mortality among patients with CnsKP infection in Taiwan. Particular attention was focused on the outcome related to different levels of disease severity. Methods: Patients with CnsKP infections from 11 medical centers and four regional hospitals in Taiwan were enrolled in 2013. Carbapenem non-susceptibility was defined as a minimum inhibitory concentration of ≥2 mg/L for imipenem or meropenem. Predictors of 14-day mortality were determined using the Cox proportional regression model. The influence of infection severity on the impact of appropriate use of antimicrobials on 14-day mortality was determined using the Acute Physiology and Chronic Health Evaluation (APACHE) II score. Results: Overall 14-day mortality was 31.8% (49/154 patients). Unadjusted mortality for appropriate antimicrobial therapy was 23.1% (18/78 patients). Appropriate therapy was independently associated with reduced mortality (hazard ratio [HR], 0.44; 95% confidence interval [CI], 0.24 to 0.80; P = 0.007). A subgroup analysis revealed that the benefit of appropriate therapy was limited to patients with higher APACHE II scores (HR for patients with scores >15 and ≤35, 0.46 [95% CI, 0.23 – 0.92]; HR for those with scores >35, 0.14; 95% CI, 0.02 – 0.99). Conclusions: In conclusion, appropriate antimicrobial therapy significantly reduces 14-day mortality for CnsKP infections. Survival benefit is more notable among more severely ill patients.
    日期: 2015-04
    關聯: Journal of Microbiology, Immunology and Infection. 2015 Apr;48(2, Suppl. 1):S40.
    Link to: http://dx.doi.org/10.1016/j.jmii.2015.02.065
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1684-1182&DestApp=IC2JCR
    顯示於類別:[蕭樑基] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    SDO1684118215000985.pdf42KbAdobe PDF547檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋